NCT01689948

Brief Summary

Alzheimer's disease (AD) is the most common cause of dementia among elderly patients. By its prevalence and its medical and social consequences, AD represents a dual challenge to public health and society. The elderly want to stay in their homes even when their lives are altered by a chronic progressive disease. Their caregivers claim in turn a support at home. But this desire is questioned because of the characteristics of the disease, e.g. the altered relational function by the cognitive impairment and the behavioural disorders associated. Outpatients non-drug therapies represent a potential support that adapts to patient with an AD or mixed dementia, especially in their milder forms. The aim of the study is to evaluate the feasibility of a weekly rehabilitation's intervention at home and its acceptability by both the patient and the caregiver. The study of its efficiency in terms of autonomy will be the next step.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 18, 2012

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 21, 2012

Completed
10 days until next milestone

Study Start

First participant enrolled

October 1, 2012

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2014

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
Last Updated

October 15, 2014

Status Verified

October 1, 2014

Enrollment Period

1.6 years

First QC Date

September 18, 2012

Last Update Submit

October 14, 2014

Conditions

Keywords

Home care, rehabilitation therapy, Alzheimer's disease

Outcome Measures

Primary Outcomes (1)

  • Evaluation of the mean scores of Instrumental Activities of Daily Living (IADL)

    The main objective is to compare the mean scores of Instrumental Activities of Daily Living (IADL) observed at inclusion (day 0) with those observed 27 weeks later (meaning 3 months after the last of the twelfth weekly session of at home rehabilitation therapy).

    27 weeks

Secondary Outcomes (11)

  • Evaluation of the mean scores of Instrumental Activities of Daily Living (IADL)

    5 weeks

  • Evaluation of the mean scores of Instrumental Activities of Daily Living (IADL)

    13 weeks

  • Evaluation of the mean scores of Neuro Psychiatric Inventory (NPI)

    27 weeks

  • Evaluation of the mean scores of Neuro Psychiatric Inventory (NPI)

    5 weeks

  • Evaluation of the mean scores of Neuro Psychiatric Inventory (NPI)

    13 weeks

  • +6 more secondary outcomes

Study Arms (1)

Home rehabilitation therapy

EXPERIMENTAL

12 weekly sessions of Home rehabilitation therapy

Behavioral: Home rehabilitation therapy

Interventions

12 sessions of home rehabilitation therapy

Home rehabilitation therapy

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Aged 65 and over
  • AD or mixed dementia (DSM IV TR criteria), documented by a neuropsychological assessment and a brain imaging
  • Living at home
  • Having a caregiver (more than 2 visits per week)
  • Agreement for the study
  • More than 2 patient's visits per week
  • Agreement for the study

You may not qualify if:

  • Life expectancy less than 1 year
  • Guardianship
  • Already having a rehabilitation program's therapy
  • Participation in a pharmacological study
  • \- Medical condition requiring regular care

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bellier Hospital, CHU of Nantes

Nantes, 44093, France

Location

MeSH Terms

Conditions

Alzheimer Disease

Condition Hierarchy (Ancestors)

DementiaBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental Disorders

Study Officials

  • Gilles Berrut, Pr

    Bellier Hospital, CHU of Nantes

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 18, 2012

First Posted

September 21, 2012

Study Start

October 1, 2012

Primary Completion

May 1, 2014

Study Completion

September 1, 2014

Last Updated

October 15, 2014

Record last verified: 2014-10

Locations